ResMed (RMD) operating income was $1.9B in FY2026 (+13% YoY). The tables below show the complete quarterly and annual operating income history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Operating Income
Fiscal Year
Operating Income
YoY
2026
$1.9B
+13%
2025
$1.7B
+22%
2024
$1.4B
+21%
2023
$1.1B
+14%
2022
$1.0B
+10%
2021
$912M
+13%
2020
$810M
+38%
2019
$589M
+5%
2018
$560M
+28%
2017
$438M
+1%
2016
$436M
+7%
2015
$409M
-1%
2014
$411M
+16%
2013
$355M
+21%
2012
$294M
+10%
2011
$267M
+11%
2010
$240M
+26%
2009
$190M
Recent Quarterly Operating Income
Quarter
Operating Income
Q2 2026
$449M
Q1 2026
$500M
Q4 2025
$498M
Q3 2025
$462M
Q2 2025
$455M
Q1 2025
$426M
Q4 2024
$417M
Q3 2024
$387M
Q2 2024
$381M
Q1 2024
$375M
Q4 2023
$339M
Q3 2023
$289M
Source: RMD on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.